Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Evoke Pharma Inc (EVOK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7979
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions for nausea, bloating, upper abdominal pain, prolonged fullness, early satiety and vomiting. The company operates through other commercial organizations and external consultants to develop novel product candidates. It also develops programs with associated clinical data, products containing previously approved compounds, and others. Evoke Pharma is headquartered in Solana Beach, California, the US.

Evoke Pharma Inc (EVOK) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 12
Evoke Pharma Enters into Partnership with Spaulding Clinical Research 13
Equity Offering 14
Evoke Pharma Plans to Raise up to USD16 Million in Public Offering of Shares 14
Evoke Pharma Raises USD8 Million in Public Offering of Shares 15
Evoke Pharma Raises USD4.5 Million in Registered Direct Offering 16
Evoke Pharma to Raise USD10 Million in Registered Direct Offering 18
Evoke Pharma Raises USD5 Million in Public Offering of Shares 19
Evoke Pharma to Raise Funds through Public Offering of Shares 20
Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 21
Evoke Pharma Inc – Key Competitors 23
Evoke Pharma Inc – Key Employees 24
Evoke Pharma Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 09, 2018: Evoke Pharma reports second quarter 2018 results and recent highlights 26
May 14, 2018: Evoke Pharma Reports First Quarter 2018 Results and Highlights 27
Mar 07, 2018: Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights 28
Nov 14, 2017: Evoke Pharma Reports Third Quarter 2017 Results and Highlights 29
Aug 14, 2017: Evoke Pharma Reports Second Quarter 2017 Results and Highlights 30
May 15, 2017: Evoke Pharma Reports First Quarter 2017 Results 31
May 15, 2017: Evoke Pharma Q1 net loss increases 32
Mar 15, 2017: Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results 33
Product News 34
10/27/2017: Evoke Pharma Announces Conference Call to Review the Successful Results of Comparative Exposure Pharmacokinetic Study for Gimoti 34
10/23/2017: Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti 35
10/04/2017: Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference 36
09/05/2017: Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference 37
05/15/2017: Evoke Pharma Provides Update on Gimoti 38
02/15/2018: Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti 39
Product Approvals 40
Sep 12, 2017: Evoke Pharma Completes Dosing for Gimoti Comparative Exposure Pharmacokinetic Study 40
Aug 14, 2017: Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti 41
May 31, 2017: Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti 42
Apr 04, 2017: Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharma’s Proposed Comparative Exposure PK Trial for Gimoti NDA 43
Feb 15, 2017: FDA Exempts Evoke from Requirement for Human Factor Validation Study 44
Clinical Trials 45
May 10, 2017: Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 45
Mar 21, 2017: Evoke Pharmas Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017 46
Jan 09, 2017: Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference 47
Jan 04, 2017: Evoke Provides Additional Data Demonstrating Statistically Significant Benefit for Gimoti in Moderate to Severe Patients in Phase 3 Diabetic Gastroparesis Trial 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 12
Evoke Pharma Enters into Partnership with Spaulding Clinical Research 13
Evoke Pharma Plans to Raise up to USD16 Million in Public Offering of Shares 14
Evoke Pharma Raises USD8 Million in Public Offering of Shares 15
Evoke Pharma Raises USD4.5 Million in Registered Direct Offering 16
Evoke Pharma to Raise USD10 Million in Registered Direct Offering 18
Evoke Pharma Raises USD5 Million in Public Offering of Shares 19
Evoke Pharma to Raise Funds through Public Offering of Shares 20
Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 21
Evoke Pharma Inc, Key Competitors 23
Evoke Pharma Inc, Key Employees 24

List of Figures
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aimpoint AB:企業の戦略・SWOT・財務情報
    Aimpoint AB - Strategy, SWOT and Corporate Finance Report Summary Aimpoint AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and r …
  • General Electric Co (GE)-医療機器分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Optex Systems Holdings, Inc.:企業の戦略・SWOT・財務情報
    Optex Systems Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Optex Systems Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Square Inc:企業のM&A・事業提携・投資動向
    Square Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Square Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Royal IHC:石油・ガス:M&Aディール及び事業提携情報
    Summary Royal IHC (IHC), formerly IHC Merwede BV is a shipbuilding company that offers engineering solutions. The company’s product portfolio includes dredging equipment, motion control and automation equipment, decommissioning equipment, offshore foundation equipment and metal construction kits. IH …
  • Telephonics Corp:企業の戦略的SWOT分析
    Telephonics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cathedral Energy Services Ltd (CET):企業の財務・戦略的SWOT分析
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, production testing services, measurement while drilling services a …
  • Independent Electricity System Operator:企業の戦略的SWOT分析
    Independent Electricity System Operator - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Kao Corp (4452):企業の財務・戦略的SWOT分析
    Kao Corp (4452) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Extraction Oil & Gas Inc (XOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Extraction Oil & Gas Inc (Extraction Oil & Gas), formerly known as Extraction Oil & Gas LLC, is an independent upstream oil and gas company which focuses on the acquisition, development and production of oil, natural gas and natural gas liquids reserves in the Rocky Mountains. The company pr …
  • NovaMedica LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaMedica LLC (NovaMedica) is a pharmaceutical company that develops drugs for various therapeutic areas. The company offers drugs in the areas of cardiovascular, central nervous system, dermatology, endocrinology, gynecology, infectious disease, gastrointestinal, pediatric, woman’s health, …
  • PNM Resources Inc (PNM):企業の財務・戦略的SWOT分析
    PNM Resources Inc (PNM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ngai Hing Hong Co Ltd (1047)
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Comstock Resources Inc (CRK):石油・ガス:M&Aディール及び事業提携情報
    Summary Comstock Resources Inc (Comstock) is an oil and gas company that acquires, develops, explores and produces oil and natural gas properties. The company provides oil and gas operations such as Eagle ford Shale, Haynesville Shale and Tuscaloosa Marine Shale in East Texas and North Louisiana, So …
  • Arab Petroleum Investments Corp:企業の戦略的SWOT分析
    Arab Petroleum Investments Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Campbell Soup Company (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Company (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Rosenergoatom Concern:電力:M&Aディール及び事業提携情報
    Summary Rosenergoatom Concern (Rosenergoatom) is a subsidiary of Atomenergoprom, which is electric power generation company, mainly supplying electrical and thermal energy in Russia. The company’s major activities include design, construction, operation and decommissioning of nuclear power plants. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆